Mesoporous silica nanoparticles (MSNs) are emerging as powerful nanomedicine platforms for targeted drug delivery due to their high surface area, tunable pore structures, and biocompatibility. This application note demonstrates how engineered mesoporous silica nanoparticles with tunable pore morphology and size enable efficient encapsulation and delivery of diverse therapeutic cargos, including small molecules, oligonucleotides, proteins, and antibodies.
We also demonstrate how mesoporous silica nanoparticles engineered by nanoComposix enable targeted mRNA delivery that induces HIV-specific immune responses, illustrating their promise for vaccine development and next-generation therapeutics. Together, this work provides researchers with a practical overview of design principles and biomedical applications of mesoporous silica nanoparticles, positioning MSNs as a versatile platform for accelerating the development of innovative drug delivery systems and nanomedicine therapies.
Download the application note to explore MSN design considerations and representative performance data.
Ready to advance your drug delivery platform? Connect with our nanomedicine experts to develop a custom drug delivery system solution for your therapeutic program.